MedPath

gamma-Hydroxybutyric acid

Generic Name
gamma-Hydroxybutyric acid
Brand Names
Xywav
Drug Type
Small Molecule
Chemical Formula
C4H8O3
CAS Number
591-81-1
Unique Ingredient Identifier
30IW36W5B2
Background

Gamma hydroxybutyric acid, commonly abbreviated GHB, is a therapeutic drug which is illegal in multiple countries. It is currently regulated in the US and sold by Jazz Pharmaceuticals under the name Xyrem. However, it is important to note that GHB is a designated Orphan drug (in 1985). Today Xyrem is a Schedule III drug; however GHB remains a Schedule I drug and the illicit use of Xyrem falls under penalties of Schedule I. GHB is a naturally occurring substance found in the central nervous system, wine, beef, small citrus fruits and almost all other living creatures in small amounts. It is used illegally under the street names Juice, Liquid Ecstasy or simply G, either as an intoxicant, or as a date rape drug. Xyrem is a central nervous system depressant that reduces excessive daytime sleepiness and cataplexy in patients with narcolepsy.

Indication

Used as a general anesthetic, to treat conditions such as insomnia, clinical depression, narcolepsy, and alcoholism, and to improve athletic performance.

Associated Conditions
-
Associated Therapies
-
stocktitan.net
·

Stocks to Watch in the Battle Against Fentanyl and Dangerous Drugs

Greenlane Holdings (GNLN) launches fentanyl, xylazine, and drink spike detection test strips under Safety Strips, Inc. brand, available from Sept 25th, with shipments starting Oct 1st. Amid growing opioid crisis, Greenlane aims to provide affordable, easy-to-use solutions, leveraging its extensive sales, marketing, and distribution network. The global opioid overdose treatment market is projected to reach $1.54 billion in 2024.
newsfilecorp.com
·

Safe Supply Streaming Portfolio Company Safety Strips Launches Affordable and Reliable Drug Detection Strips

Safe Supply Streaming's portfolio company, Safety Strips, launches affordable drug detection strips to combat fentanyl, xylazine, and drink spiking, in response to new California legislation. The strips will be available via Greenlane Holdings' distribution channels starting September 25, 2024.
finance.yahoo.com
·

Safe Supply Streaming Portfolio Company Safety Strips Launches Affordable and Reliable ...

Safe Supply Streaming Co Ltd. launches Safety Strips Inc. to combat fentanyl, xylazine, and drink spiking, aligning with California's AB 1013 legislation. Products available from September 25, 2024, through Greenlane Holdings' distribution network.
news.bloomberglaw.com
·

Jazz Pharma to Fight FDA in Court Over Rival Sleep Drug Approval

Jazz Pharmaceuticals challenges FDA's approval of rival Lumryz, arguing it violates the Orphan Drug Act by using 'clinical superiority' to bypass Xywav's exclusivity. The case hinges on the interpretation of 'same drug' and could impact FDA's authority and orphan drug protections.

Trends and characteristics in ketamine use among US adults

Ketamine use in the US increased significantly from 2015 to 2022, with a notable rise among adults with and without depression initially, but only among those without depression in later years. Depression was linked to higher ketamine use odds in 2015-2019. Sociodemographic factors and other drug use also influenced ketamine use trends.
bbc.com
·

GHB: Killer drug to be made a Class B substance

GHB, a drug linked to serious crimes including murder and sexual assault, will be reclassified from Class C to Class B in the UK, leading to tougher penalties. This change follows a recommendation by the Advisory Council on the Misuse of Drugs and aims to protect people from harm. Associated substances GBL and 1,4-BD will also be moved to Class B.
© Copyright 2025. All Rights Reserved by MedPath